Please login to the form below
STS
This page shows the latest STS news and features for those working in and with pharma, biotech and healthcare.
ICR and NeoPhore announce immuno-oncology collaboration to develop new cancer drugs
The partnership is the 4th collaboration agreement NeoPhore has signed since 2017, having teamed up with University of Turin, St George’s University of London and Memorial Sloan Kettering Cancer Center.
Latest news
-
AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma
of inflammatory phenotype,” explained David Jackson, professor of respiratory medicine and clinical lead for Guy’s and St Thomas’ Asthma Service.
-
Eisai and Washington University to develop neurodegenerative disease therapies
Eisai and Washington University School of Medicine in St Louis have entered into a research collaboration agreement aimed at developing new treatments for Alzheimer’s disease (AD), Parkinson’s disease (PD) ... By collaborating with world-leading
-
Best practice in UK dermatology care celebrated at second national awards
Winner. Vital 5 Implementation in a Dermatology Day Centre by Guys and St Thomas' NHS Foundation Trust.
-
COVID-19 linked to long-term neurologic disorders in new US study
Washington University School of Medicine in St Louis and the Veterans Affairs St Louis Health Care system revealed.
-
Biogen’s tofersen shows promise in rare form of ALS in new data analysis
director at Washington University School of Medicine, St Louis.
More from news
Approximately 2 fully matching, plus 157 partially matching documents found.
Latest Intelligence
-
Lessons from a pandemic – holistic strategy in the time of coronavirus
Janice MacLennan is founder of the NMBLR app and CEO at St Clair Consultancy.
-
Alzheimer’s: the search for a cure
gene-editing specialist Sangamo for rights to tau-targeting drug ST-501 as part of a broader R&D alliance.
-
Combining therapies and combining research
Professor Anthony Coates is Professor of Medical Microbiology at St George’s University in London and Founder of Helperby Therapeutics.
-
The challenges of making genomics a reality for patients today, not tomorrow
st. birthday. It remains one of the most common genetic conditions and the UK has the second highest number of patients in the world.
-
Deal Watch - May 2017
More recent data reported in FiercePharma (1. st. May) shows Amgen has cash overseas of $34bn, Gilead $27bn and Merck &Co $22bn.
More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.
Latest appointments
-
Amanda Pritchard becomes NHS England’s first female chief executive
This includes serving as chief executive of Guy’s and St Thomas’ NHS Foundation Trust, London and deputy chief executive at Chelsea and Westminster NHS Foundation Trust.
-
Porterhouse announces members of medical advisory group
She graduated from St Bartholomew’s and the London School of Medicine and Dentistry in 2001, working as a pathologist in the NHS until 2015.
-
New hires at Abbott, Kite and Arrakis Therapeutics
He worked as executive vice president of Medical Devices, in which he oversaw the integration fo St.
-
Sanofi appoints immunology and inflammation research global head
at Guy's and St Thomas' Foundation Trust Hospital.
-
New hire at Eurocom Healthcare Communications
Knox's practical healthcare experience ranges from work as an NHS administrator on the wards at St Mary's Hospital to demonstrating anatomy to medical students at St George's University
More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.
Latest from PMHub
-
MarketsResearch.biz
Address:. 3626 N Hall St. Dallas. TX. 75219. United States.
-
Perceptive Communicators
Address:. Perceptive Communicators. Suite 2.2, , 65 Bath St,. Glasgow. Glasgow.
-
Focusing on what matters most
02089716400. Address:. Tuition House. 27-37 St George's Road, Wimbledon. Wimbledon. London. -
-
Sight-saving MedTech sleep mask could save the NHS multimillions
3. Based on research undertaken by Ashford and St Peter’s NHS Foundation Trust, improving patient outcomes with an earlier stage intervention could save the NHS £3, 000 per patient. ... Commenting on the treatment’s benefits Mr Ulrich Meyer-Bothling,
-
The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
02089716400. Address:. Tuition House. 27-37 St George's Road, Wimbledon. Wimbledon. London. -
More from PMHub
Approximately 0 fully matching, plus 244 partially matching documents found.
Subscribe to our email news alerts
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Pfizer reports positive results for elranatamab in multiple myeloma
- BMS presents positive four-year results for Opdivo combination in lung cancer
- AstraZeneca to stop post-marketing study of Andexxa following early success
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- European Commission grants two new marketing authorisations for UCB's Bimzelx
- AstraZeneca/Sanofi’s RSV antibody backed by FDA advisory committee for infants
- Janssen shares positive phase 3 results for cilta-cel in multiple myeloma
- Parkinson’s disease: past, present and future
- How to Increase Engagement During Virtual Events
- AstraZeneca to stop post-marketing study of Andexxa following early success
No results were found
PMHub
Bedrock Healthcare Communications
Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...
Latest intelligence
- Parkinson’s disease: past, present and future
- Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide...
- The 17th World Congress on Controversies in Neurology
- This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
